Granulocyte‐Macrophage Colony‐Stimulating Factor Induces Modest Increases in Plasma Human Immunodeficiency Virus (HIV) Type 1 RNA Levels and CD4+Lymphocyte Counts in Patients with Uncontrolled HIV Infection
Author(s) -
Jeffrey M. Jacobson,
Michael M. Lederman,
John Spritzler,
Hernán Valdez,
Pablo Tebas,
Gail Skowron,
Rui Wang,
J. Brooks Jackson,
Lawrence Fox,
Alan Landay,
M. Jean Gilbert,
Dorothy O’Neil,
Lynne Bancroft,
Lena AlHarthi,
Mark Z. Jacobson,
Thomas C. Merigan,
Marshall J. Glesby
Publication year - 2003
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/379899
Subject(s) - immunology , medicine , lymphocyte , lentivirus , granulocyte macrophage colony stimulating factor , sida , placebo , immunopathology , virus , granulocyte , viral disease , gastroenterology , cytokine , pathology , alternative medicine
Studies have reported that plasma human immunodeficiency virus type 1 (HIV-1) RNA levels and CD4+ lymphocyte counts in HIV-infected patients improved after treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom